REGN vs WST · P/E 14, rev $14.34B vs P/E 35, rev $2.89B
Regeneron Pharmaceuticals Inc (REGN) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the REGN and WST stock pages for the full models.
Not investment advice.